Segment Information - Schedule of Segment Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
Schedule of Segment Information [Line Items] | ||||
Product sales | $ 6,444,880 | $ 5,472,890 | $ 14,512,054 | $ 12,730,467 |
Costs of goods sold | 3,626,956 | 4,242,404 | 8,340,158 | 9,204,622 |
Gross margin | 2,817,924 | 1,230,486 | 6,171,896 | 3,525,845 |
Product development expenses | 831,858 | 1,030,502 | 1,588,705 | 2,293,053 |
Sales and marketing expenses | 696,086 | 984,957 | 1,552,744 | 1,785,880 |
Administrative expenses | 720,418 | 601,634 | 1,343,260 | 1,133,572 |
Operating expenses | 2,248,362 | 2,617,093 | 4,484,709 | 5,212,505 |
NET OPERATING INCOME (LOSS) | 569,562 | (1,386,607) | 1,687,187 | (1,686,660) |
Total Assets | 46,720,898 | 41,855,458 | 46,720,898 | 41,855,458 |
Depreciation and amortization expense | 679,037 | 681,765 | 1,365,810 | 1,359,265 |
Capital Expenditures | 155,158 | 110,741 | 484,208 | 181,097 |
Scours [Member] | ||||
Schedule of Segment Information [Line Items] | ||||
Product sales | 6,398,517 | 5,430,069 | 14,427,003 | 12,650,710 |
Costs of goods sold | 3,589,893 | 4,198,849 | 8,264,436 | 9,122,397 |
Gross margin | 2,808,624 | 1,231,220 | 6,162,567 | 3,528,313 |
Product development expenses | 93,011 | 65,598 | 186,496 | 95,093 |
Sales and marketing expenses | 634,846 | 855,513 | 1,421,983 | 1,525,252 |
Administrative expenses | ||||
Operating expenses | 727,857 | 921,111 | 1,608,479 | 1,620,345 |
NET OPERATING INCOME (LOSS) | 2,080,767 | 310,109 | 4,554,088 | 1,907,968 |
Total Assets | 24,612,357 | 23,240,545 | 24,612,357 | 23,240,545 |
Depreciation and amortization expense | 345,512 | 342,362 | 698,034 | 681,281 |
Capital Expenditures | 151,808 | 93,338 | 474,185 | 132,812 |
Mastitis [Member] | ||||
Schedule of Segment Information [Line Items] | ||||
Product sales | 46,363 | 42,821 | 85,051 | 79,757 |
Costs of goods sold | 37,063 | 43,555 | 75,722 | 82,225 |
Gross margin | 9,300 | (734) | 9,329 | (2,468) |
Product development expenses | 710,745 | 928,531 | 1,339,657 | 2,131,473 |
Sales and marketing expenses | 61,240 | 129,444 | 130,761 | 260,628 |
Administrative expenses | ||||
Operating expenses | 771,985 | 1,057,975 | 1,470,418 | 2,392,101 |
NET OPERATING INCOME (LOSS) | (762,685) | (1,058,709) | (1,461,089) | (2,394,569) |
Total Assets | 15,924,755 | 17,107,377 | 15,924,755 | 17,107,377 |
Depreciation and amortization expense | 314,175 | 319,727 | 628,834 | 638,445 |
Capital Expenditures | 1,079 | 17,403 | 7,752 | 48,285 |
Other [Member] | ||||
Schedule of Segment Information [Line Items] | ||||
Product sales | ||||
Costs of goods sold | ||||
Gross margin | ||||
Product development expenses | 28,102 | 36,373 | 62,552 | 66,487 |
Sales and marketing expenses | ||||
Administrative expenses | 720,418 | 601,634 | 1,343,260 | 1,133,572 |
Operating expenses | 748,520 | 638,007 | 1,405,812 | 1,200,059 |
NET OPERATING INCOME (LOSS) | (748,520) | (638,007) | (1,405,812) | (1,200,059) |
Total Assets | 6,183,786 | 1,507,536 | 6,183,786 | 1,507,536 |
Depreciation and amortization expense | 19,350 | 19,676 | 38,942 | 39,539 |
Capital Expenditures | $ 2,271 | $ 2,271 |
X | ||||||||||
- Definition Amount of significant additions in the period in other assets (current, noncurrent, or unclassified). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Future cash outflow to pay for purchases of fixed assets that have occurred. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives, and reduction in quantity of natural resource due to consumption directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|